Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Sue Wakelin

Sue Wakelin is a care homes pharmacist and member of the medicines management team at NHS Southampton City CCG.

Contact Info


Recent stories

  • Primary-care overprescribing of rivaroxaban in patients without atrial fibrillationSubscription

    18 DEC 2017

    There is a national prescribing trend for rivaroxaban (Xarelto; Bayer), one of four drugs known as direct oral anticoagulants (DOACs), and prescription is steadily rising. The drug has six licensed indications, with four different dosages and at least five possible durations of therapy, depending on the condition being treated. Anecdotal evidence suggests that some patients have inadvertently remained on rivaroxaban in the long term in cases where the drug had been indicated for only a short-

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.